Article
<i>In Vivo</i> Targeting of Tumor Endothelial Cells by Systemic Delivery of Lentiviral Vectors
23 Jul 2003
Abstract excerpt
Tumor angiogenesis is a rate-limiting factor for tumor growth, and the endothelial cells of tumor vessels display specific features that can be exploited for the selective delivery of cancer therapeutics. To specifically target exogenous genes to angiogenic tumor vessels, we generated a panel of vesicular stomatitis virus-pseudotyped lentiviral vectors (LVs) engineered for endothelial cell (EC)-specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
